StockMarketWire.com - Motif Bio said data about its iclaprim antibiotic treatment would be presented at an upcoming industry conference in Lisbon.

The European Society of Clinical Microbiology and Infectious Diseases and American Society For Microbiology conference would be held on 4-7 of September.

The event focused on the development of new antimicrobial agents for antimicrobial resistance.




Story provided by StockMarketWire.com